These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 33198246)
1. Brain Metastasis from Unknown Primary Tumour: Moving from Old Retrospective Studies to Clinical Trials on Targeted Agents. Balestrino R; Rudà R; Soffietti R Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33198246 [TBL] [Abstract][Full Text] [Related]
2. Does Cancer of Unknown Primary (CUP) Truly Exist as a Distinct Cancer Entity? Bochtler T; Krämer A Front Oncol; 2019; 9():402. PubMed ID: 31165045 [TBL] [Abstract][Full Text] [Related]
3. Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm? Olivier T; Fernandez E; Labidi-Galy I; Dietrich PY; Rodriguez-Bravo V; Baciarello G; Fizazi K; Patrikidou A Cancer Treat Rev; 2021 Jun; 97():102204. PubMed ID: 33866225 [TBL] [Abstract][Full Text] [Related]
4. The role of molecular profiling in the diagnosis and management of metastatic undifferentiated cancer of unknown primary Dermawan JK; Rubin BP Semin Diagn Pathol; 2021 Nov; 38(6):193-198. PubMed ID: 33309276 [TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic and therapeutic management of cancer of an unknown primary. Pavlidis N; Briasoulis E; Hainsworth J; Greco FA Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453 [TBL] [Abstract][Full Text] [Related]
7. Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary Site. Qaseem A; Usman N; Jayaraj JS; Janapala RN; Kashif T Cureus; 2019 Sep; 11(9):e5552. PubMed ID: 31695975 [TBL] [Abstract][Full Text] [Related]
8. The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort Study. Hannouf MB; Winquist E; Mahmud SM; Brackstone M; Sarma S; Rodrigues G; Rogan PK; Hoch JS; Zaric GS Pharmacoecon Open; 2018 Sep; 2(3):255-270. PubMed ID: 29623630 [TBL] [Abstract][Full Text] [Related]
9. Histopathological Evaluation and Molecular Diagnostic Tests for Peritoneal Metastases with Unknown Primary Site-a Review. Bhatt A; Mishra S; Glehen O Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):15-29. PubMed ID: 37359927 [TBL] [Abstract][Full Text] [Related]
10. "Metastatic Cancer of Unknown Primary" or "Primary Metastatic Cancer"? Kolling S; Ventre F; Geuna E; Milan M; Pisacane A; Boccaccio C; Sapino A; Montemurro F Front Oncol; 2019; 9():1546. PubMed ID: 32010631 [TBL] [Abstract][Full Text] [Related]
11. Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036). Wang H; Ou Q; Li D; Qin T; Bao H; Hou X; Wang K; Wang F; Deng Q; Liang J; Zheng W; Wu X; Wang X; Shao YW; Mou Y; Chen L Cancer; 2019 Oct; 125(20):3535-3544. PubMed ID: 31287555 [TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy: a new diagnostic, predictive and prognostic window in cancers of unknown primary. El Rassy E; Khaled H; Pavlidis N Eur J Cancer; 2018 Dec; 105():28-32. PubMed ID: 30388661 [TBL] [Abstract][Full Text] [Related]
13. Exploring the biology of cancer of unknown primary: breakthroughs and drawbacks. Kamposioras K; Pentheroudakis G; Pavlidis N Eur J Clin Invest; 2013 May; 43(5):491-500. PubMed ID: 23480555 [TBL] [Abstract][Full Text] [Related]
14. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study. Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304 [TBL] [Abstract][Full Text] [Related]
15. Survival outcome differences based on treatments used and knowledge of the primary tumour site for patients with cancer of unknown and known primary in Ontario. Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS Curr Oncol; 2018 Oct; 25(5):307-316. PubMed ID: 30464680 [TBL] [Abstract][Full Text] [Related]
16. [Diagnostics and therapy for neuroendocrine neoplasia of an unknown primary - a plea for open exploration]. Begum N; Hubold C; Buchmann I; Thorns C; Bouchard R; Lubienski A; Schlöricke E; Zimmermann M; Lehnert H; Bruch HP; Bürk CG Zentralbl Chir; 2014 Jun; 139(3):284-91. PubMed ID: 23508839 [TBL] [Abstract][Full Text] [Related]
17. Survival outcomes following craniotomy for intracranial metastases from an unknown primary. Gough M; Nielsen M; Coulter IC; Holliman D Int J Clin Oncol; 2020 Aug; 25(8):1475-1482. PubMed ID: 32358736 [TBL] [Abstract][Full Text] [Related]
18. New Genetic Technologies in Diagnosis and Treatment of Cancer of Unknown Primary. Krawczyk P; Jassem J; Wojas-Krawczyk K; Krzakowski M; Dziadziuszko R; Olszewski W Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884492 [TBL] [Abstract][Full Text] [Related]
19. Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature. Overby A; Duval L; Ladekarl M; Laursen BE; Donskov F Clin Genitourin Cancer; 2019 Feb; 17(1):e32-e37. PubMed ID: 30268423 [TBL] [Abstract][Full Text] [Related]
20. The current evidence for a biomarker-based approach in cancer of unknown primary. El Rassy E; Pavlidis N Cancer Treat Rev; 2018 Jun; 67():21-28. PubMed ID: 29751335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]